MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.5 USD | -1.09% |
|
-5.00% | +14.23% |
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.9
USD
Average target price
141.9
USD
Spread / Average Target
+12.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.23% | 319B | |
| +39.82% | 731B | |
| +31.34% | 586B | |
| -7.31% | 348B | |
| +0.86% | 273B | |
| +13.47% | 235B | |
| -6.63% | 203B | |
| +7.49% | 202B | |
| +4.51% | 159B | |
| -2.05% | 158B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement
